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Background: Metanephric neoplasms comprised a spectrum of kidney tumors containing renal epithelial or
stromal cells or both, including metanephric adenoma, metanephric stromal tumor, and metanephric
adenofibroma. The majority of cases were benign; only one case of “metanephric adenosarcoma” had been
reported in the English literature.
History: We present the case of a 69-year-old man who developed a neoplasm composed of renal epithelial
component identical to metanephric adenoma combined with malignant spindle-cell stroma. The epithelial component
was positive for CD57, AE1/AE3, but negative for WT-1, CD56, SYN, and CgA; whereas the sarcomatous component was
negative for epithelial markers, SMA, Caldesmon, MyoD1, Myogenin, and S-100; and positive for vimentin, CD10, and WT1
focally. No specific sarcoma differentiation was apparent in the stroma by immunohistochemistry, and no SYT-SS18
rearrangement or BRAF mutation was detected by molecular analysis.
A diagnosis of metanephric adenosarcoma was made because of the morphological features and immunohitochemistry
and molecular pathology analysis.
Clinical significance: We believe that metanephric adenosarcoma should be in the expanded spectrum of metanephric
neoplasia as a malignant stromal variant.
Conclusions: We report a rare case of metanephric adenosarcoma with immunohistochemistry and molecular analysis
and emphasize the histopathologic features and differential diagnosis of the rare lesion to promote a better and broader
understanding of this less understood subject.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
13000_2014_179
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Metanephric neoplasms, as uncommon renal tumors
[1], have so far been reported to encompass metaneph-
ric adenoma (purely epithelial neoplasm), metanephric
stromal tumor (purely stromal tumor), and metanephric
adenofibroma (biphasic tumor). Most of these tumors
have been known for their benign behavior. Before
present report, only one case of “metanephric adenosar-
coma” was described by M. M. Picken et al. as a meta-
nephric tumor with malignant stroma [2]. Our case
represents the second report of this lesion in the* Correspondence: zhupengcheng@hust.edu.cn
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pathologic analysis. The study was approved by the Ethics
Committee of Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan,
China. Written informed consent was obtained from the
patient prior to death.Case report
A 69-year-old, previously healthy Chinese man under-
went a routine physical examination three months ago,
and a mass was discovered in his left kidney with ultra-
sound examination and computed tomography (Figure 1
A and B). Based on these findings, a clinical diagnosis of
a malignant tumor of uncertain type with invasion of
splenic hilum and adjacent peritoneum indicated a needThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Radiological features of the tumor. (A) Ultrasound
examination showed a space-occupying mass of low echogenicity
within irregular margin. (B) Computed tomography showed a large
mass in the left kidney.
Figure 2 Macroscopic features of the kidney. There was an 11
cm x 8 cm grey white, hard solid mass in the renal parenchyma
cross section without cysts.
Table 1 Antibodies and dilutions used in the evaluation
of metanephric adenosarcoma of the kidney
Antibody Dilution Source epithelium stroma
Vimentin prediluted Dako - +
CD10 1:20 Dako - +
AE1/AE3 1:20 Dako + -
CD57 1:50 Dako + -
WT-1 prediluted Dako - −/+
EMA 1:100 Dako + -
CK7 1:200 Dako + -
CD117 1:50 Dako + -
CD56 1:100 Novocastra - -
Syn 1:100 Dako - -
CgA 1:400 Dako - -
CD34 1:50 Dako - -
α-inhibin 1:50 Dako - -
SMA prediluted Dako - -
Caldesmon prediluted Dako - -
MyoD1 1:200 Dako - -
Myogenin 1:50 Dako - -
S-100 prediluted Dako - -
CD99 1:50 Dako - -
Ki67 1:40 Dako <1% 60%
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surgery. Left kidney resection was performed subse-
quently as well as spleen and part of peritoneum.
Grossly, there was an 11 cm × 8 cm grey white, hard
solid mass in the renal parenchyma cross section with-
out cysts (Figure 2). Several hard nodes could be
touched in adipose tissue of hilum of spleen and periton-
eum. Histopathological examination of the mass showed a
biphasic tumor composed of benign epithelium and ma-
lignant spindle shaped mesenchymal cells. Similar mor-
phological features were found in the soft tissue in hilum
of spleen and peritoneum.
The patient died of infection and multisysterm organ
failure approximately two weeks after the surgery.
Methods
Surgical specimen was fixed in 10% buffered neutral for-
malin and paraffin sections were stained with hematoxylin
and eosin.
Immunostaining was performed by an enhancement
method based on repetitive microwave heating of slidesthat were placed into 0.01 M citrate buffer at pH 6.0. A
panel of antibodies (Table 1) was used. Binding of pri-
mary antibodies was visualized with an Envision two-step
method. Diaminobenzidine was used as the chromogen.
Nuclei were stained with Mayer’s hematoxylin. Appropri-
ate positive and negative controls were included.
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embedded 5-μm sections were deparaffinized and the
locus-specific probe (Vysis LSI SYT [18q11.2] Dual-Color,
Break-Apart Rearrangement Probe) was used according to
the manufacturer’s protocol. The fluorescence signals were
analyzed using an Olympus BX51 fluorescence micro-
scope (Olympus, Tokyo, Japan) equipped with appropriate
filters and imaged using Vysis software. At least 100 cells
were scored.
For BRAF mutation analysis, paraffin-embedded tissue
samples were macrodissected to remove stromal contam-
ination and to ensure tumor cellularity of ≥80%. Briefly,
DNA extracted from the case was amplified and se-
quenced, using the BRAF Pyro Kit (QIAGEN) designed to
detect mutations in codon 600. The kit was used accord-
ing to the manufacturer’s instructions. GTCTCAGTCGT
ATGTAGTCTAG was used as the nucleotide dispensation
order.
Results
Microscopically, the unencapsulated tumor consisted of
epithelium and stroma components (Figure 3A and B).
The relative proportion of stroma to epithelium in the
sections varied over a wide range. The two components
were frequently intimately associated with each other in
the tumor with sharp border. Some areas were almostFigure 3 Histopathological features of the tumor. The unencapsulated
areas were predominantly composed of epithelium identical to metanephr
identical to high-grade sarcomatous tumor (H & E, ×200); (C) there were hy
round and tightly packed in MA area (H & E, ×400). (D) There were highly c
atypia and frequent mitosis in sarcomatous area (H & E, ×400).entirely composed of epithelium identical to MA
(Figure 3C). Others were predominantly stromal, identical
to high-grade sarcomatous tumor (Figure 3D).
In benign epithelium area, there were hypercellular
uniform cells in solid-acini pattern, Papillary architecture
could be seen focally, and no Ductal and glomeruloid
structures could be seen. No psammoma bodies or osse-
ous metaplasia were observed either. Tumors cells were
small, round and tightly packed. Motitic figures were
rare and absent. There were no atypical ones either. In
malignant stroma area, there were highly cellular, con-
sisting of polymorphic spindle cells with obvious nuclear
atypia and frequent mitosis (16/10 high power fields).
Immunohistochemical results showed that the epithelial
component was positive for CD57 (Figure 4A), AE1/AE3
(Figure 4G), cytokeratin (CK) 7, epithelial membrane
antigen (EMA) (Figure 4C) and CD117 (Figure 4F);
other markers including WT-1 (Figure 4B), CD10,
CD56, synaptophysin (Syn), Chromogranin A (CgA), CD34
and α-inhibin were negative. The stromal spindle cells were
positive for Vimentin (Figure 4D) and CD10 (Figure 4E),
and scattered WT-1 staining (Figure 4B), but negative for
smooth muscle actin (SMA), Caldesmon, Desmin, MyoD1,
Myogenin, S-100, HMB45, MelanA, CD99 and TFE3. The
Ki-67 labeling indices were up to 60% in sarcomatous elem-
ent and <1% in epithelial element (Figure 4H), respectively.tumor consisted of epithelium and stroma components. (A) Some
ic adenoma (H & E, ×200); (B) some areas were predominantly stromal,
percellular uniform cells in solid-acini pattern, and the cells were small,
ellular, consisting of polymorphic spindle cells with obvious nuclear
Figure 4 Immunohistochemical findings of the biphasic tumor: (A) CD57; (B) WT1; (C) EMA; (D) Vimentin; (E) CD10; (F) CD117;
(G) AE1/AE3; (H) Ki67. (A-H, ×200).
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sult since more than 90% of the counted cells didn’t show
separated green and orange signals indicative of rearrange-
ment of the SYT gene. Mutation analysis showed that no
BRAF V600E mutations were detected in this case.
Discussion
Metanephric neoplasms comprised a spectrum of kidney
tumors containing renal epithelial or stromal cells or both
[1,3]. The majority of cases are usually benign without
atypical histological features in not only epithelial compo-
nent but also stromal one; Metanephric adenoma (MA) is
a common subtype in previous reports [4-6]. Rare malig-
nant or metastatic diseases have been reported [7-9]. As
we known by checking previous references, only one case
of metanephric neoplasm with malignant stroma, namedas “metanephric adenosarcoma”, was reported in 2001 [2].
Here we believe that this biphasic tumor we present is the
second case of metanephric adenosarcoma.
Microscopically, the biphasic tumor has two compo-
nents, one is epithelial element, which composed of solid
or tightly packed small, monotonous, and round acini and
focal papillary structures; tumor cells possessed scant
cytoplasm, usually pale or light pink, with small uniform
nuclei, delicate chromatin, and absent or inconspicuous
nucleoli. These morphological features favor the diagnosis
of MA. The epithelial component positive for CD57 also
gave a valuable implication of MA although there was no
immunohistochemical profile specific for metanephric
neoplasia [10-12]. However, the epithelial component was
negative for WT-1 immunohistochemically [10,13]. It was
different from a majority of reports of MA with WT-
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MA cases he reviewed shown WT-1 negative staining be-
cause of different WT-1 antibodies application [12]. We
believe that the histological features and immunohisto-
chemical profile of epithelial components were identical to
MA in our case.
To date, there is no special molecular pathology analysis
used as diagnostic one for MA [14,15]. Recently Choueiri
TK et al. confirmed BRAF V600E mutations were present
in approximately 90% of all MA cases [16], serving as a
potential valuable diagnostic tool in the differential diag-
nosis, but there was no BRAF mutation in our case.
The stromal element was composed of spindle cells
with sarcomatous features. The cells were elongated with
abundant cytoplasm and irregular nuclei, hyperchro-
matic chromatin, and plenty of atypical mitotic figures,
and necrosis was not identified. The histological features
of stroma were identical to high-grade sarcoma. Immuno-
histochemistry showed that the malignant stroma revealed
no specific differentiation direction with Vimentin and
CD10 positive staining, but others including SMA, Caldes-
mon, Desmin, MyoD1, Myogenin, S-100, HMB45, Mel-
anA and CD99, were negative.
Because the mass was a morphologically biphasic tumor
in kidney, we considered the following as differential diag-
noses of this tumor base on gross and microscopic resem-
blance: mixed epithelial and stromal tumor (MEST) with
malignant transformation, adult nephroblastoma, and
renal synovial sarcoma (SS) and sarcomatoid renal cell
carcinoma.
MEST is a rare adult renal neoplasm and microscopic
analog of our case. The tumor is ordinary benign one,
although some malignant transformation has been re-
ported [17,18]. Our case differs from MEST with malig-
nant transformation by the absence of multiple cysts
macroscopically and microscopically and lack of hobnail
appearance of the epithelial cells. A cystic renal tumor
consisting of benign epithelial and malignant stromal
components named “adenosarcoma” was reported re-
cently, and the author believed that it was a novel entity
[19]. We thought our case was a different one because it
had no cystic change. Diagnosis of adult nephroblastoma
could not be made because the tumor had no typical tri-
phasic pattern morphologically and negative WT1 stain-
ing either. Primary synovial sarcoma (SS) in kidney is a
rare distinct entity which is potentially a true biphasic
tumor [20]. The epithelial component in current tumor
lacked the cellular atypia associated with biphasic SS,
and the stromal elements were highly pleomorphic with
distinct nucleoli in contrast to the rather monomorphic
spindle cells with inconspicuous nucleoli in typical
SS. Immunohistochemistry results also contradicted the
diagnosis of SS. FISH analysis showed no rearrangement
of the SYT gene, which did not support the diagnosis ofsynovial sarcoma either. Sarcomatoid Renal Cell Carcinoma
can be ruled out since there was no carcinomatous compo-
nent and CD10-/CD57 + profile of epithelial element.
Conclusions
In summary, we believe the macroscopic, histopathologic
features of our case most closely resemble the metaneph-
ric adenosarcoma as M. M. Picken et al. named in 2001,
and metanephric adenosarcoma should be in the ex-
panded spectrum of metanephric neoplasia as a malignant
stromal variant. The diagnosis of metanephric adenosar-
coma, an extremely rare malignant renal tumor, required
the incorporation of clinical information, histopathologic
features, related markers IHC staining and molecular
pathology analysis.
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